Related references
Note: Only part of the references are listed.Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors
Juan Montoro et al.
BONE MARROW TRANSPLANTATION (2021)
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Leyre Bento et al.
BONE MARROW TRANSPLANTATION (2021)
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?
Peter Dreger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
Jeremy S. Abramson et al.
LANCET (2020)
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population
Laura Magnano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
Clementine Sarkozy et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Frederick L. Locke et al.
LANCET ONCOLOGY (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Follicular Lymphoma: A Combined Analysis on Behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR
Anna Sureda et al.
CANCER (2018)
Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma
Frank Heinzelmann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
Massimo Federico et al.
LANCET HAEMATOLOGY (2018)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Monica Cabrero et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group
Sara Alonso-Alvarez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas
F. Heinzelmann et al.
BONE MARROW TRANSPLANTATION (2016)
Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation
C. Madsen et al.
ANNALS OF ONCOLOGY (2015)
Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma
Baldeep Wirk et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group
Diego Villa et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
Brian K. Link et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry
Roel J. W. van Kampen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
Gilles Salles et al.
LANCET (2011)
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Issa F. Khouri et al.
BLOOD (2008)
High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma
Mehdi Hamadani et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma
Andrew R. Rezvani et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma
Robert Marcus et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
Abdulwahab J. Al-Tourah et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
P. Corradini et al.
LEUKEMIA (2007)
Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma
Silvia Montoto et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma:: An East German Study Group hematology and oncology study
Michael Herold et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma
DG Maloney
LEUKEMIA & LYMPHOMA (2003)
Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma
CI Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
